Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Beneficial Effects of Vitamin D3 on Reducing Antibody Titers Against Epstein-Barr Virus in Multiple Sclerosis Patients Publisher Pubmed



Najafipoor A1 ; Roghanian R1 ; Zarkeshesfahani SH1, 2 ; Bouzari M1 ; Etemadifar M3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran
  2. 2. Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Neurology, Al-Zahra Hospital, Isfahan University of Medical Sciences, Iran
  4. 4. Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan, Iran

Source: Cellular Immunology Published:2015


Abstract

Recently, the relationship between immunoreactivity to Epstein-Barr virus (EBV) and hypo-vitamin D in multiple sclerosis (MS) patients has been described. The aim of this study was to investigate whether vitamin D3 supplementation in MS patients could influence the immune response against latent EBV infection. Forty MS patients were recruited in this study. Twenty-seven patients were supplemented with 50,000. IU/week of vitamin D3 for 6. months and thirteen enrolled as controls. 25-Hydroxyvitamin D (25OHD) levels and IgG titers against EBNA1 and VCA were determined pre- and post-supplementation. All the patients were seropositive for EBV prior to vitamin D supplementation. In this cohort, 22.5% and 47.5% of the MS patients had deficient and insufficient levels of 25OHD, respectively. Our findings confirm that antibody titers against EBV in MS patients rise after the onset of the disease and indicate that vitamin D3 supplementation could limit augmentation of these titers in MS patients. © 2015 Elsevier Inc.
Related Docs
View other Related Docs
1. Association Between Acute Infectious Mononucleosis and Vitamin D Deficiency, Viral Immunology (2016)
2. Vitamin D Supplementation Could Limit T Helper-17 Response in Multiple Sclerosis, Clinical and Experimental Neuroimmunology (2014)
3. Viral Pathophysiology of Multiple Sclerosis: A Role for Epstein-Barr Virus Infection?, Pathophysiology (2011)
4. The Levels of Soluble Forms of Cd21 and Cd83 in Multiple Sclerosis, Journal of Neuroimmunology (2018)
5. Effect of High Dose Vitamin D Intake on Interleukin-17 Levels in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Neuroimmunology (2015)
6. A Comparative Study of 25 (Oh) Vitamin D Serum Levels in Patients With Multiple Sclerosis and Control Group in Isfahan, Iran, International Journal of Preventive Medicine (2010)
7. Iranian Consensus on Use of Vitamin D in Patients With Multiple Sclerosis, BMC Neurology (2016)
8. The Relation Between Vitamin D Status With Fatigue and Depressive Symptoms of Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (42)
Vahid Shaygannejad (34)
Other Related Docs
9. Preventive Effect of Vitamin D3 Supplementation on Conversion of Optic Neuritis to Clinically Definite Multiple Sclerosis: A Double Blind, Randomized, Placebo-Controlled Pilot Clinical Trial, Acta Neurologica Belgica (2013)
10. High Dose Vitamin D Intake and Quality of Life in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Neurological Research (2016)
11. Insights Into the Interplay Between Epstein-Barr Virus (Ebv) and Multiple Sclerosis (Ms): A State-Of-The-Art Review and Implications for Vaccine Development, Health Science Reports (2024)
12. Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, NeuroImmunoModulation (2015)
13. Epstein-Barr Virus and Multiple Sclerosis: Wrong Place, Wrong Time?, Neuroinflammation (2011)
14. Efficacy of Adding Vitamin D Supplementation to Interferon Β-1 in Multiple Sclerosis, Journal of Isfahan Medical School (2016)
15. Higher Latitude Is Significantly Associated With an Earlier Age of Disease Onset in Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2016)
16. Cytomegalovirus Seroposivity in Iranian Multiple Sclerosis: A Randomized Case-Control Study, Pakistan Journal of Medical Sciences (2012)
17. 25-Hydroxyvitamin D Concentrations in Patients With Optic Neuritis As a Clinically Isolated Syndrome and Healthy Controls, International Journal of Preventive Medicine (2012)
18. Serum Levels of 25(Oh) Vitamin D3 and Clinical Manifestation of First Demyelinating Attack, Journal of Isfahan Medical School (2018)
19. Cytomegalovirus and Varicella Zoster Virus Seropositivity of Iranian Patients With Multiple Sclerosis: A Population-Based Study, Journal of Neuroimmunology (2017)
20. Serum Levels of Interleukin-6 and Vitamin D at the Onset of Multiple Sclerosis and Neuromyelitis Optica: A Pilot Study, Journal of Research in Medical Sciences (2022)
21. The Effect of Vitamin D Supplementation in Disease Activity of Systemic Lupus Erythematosus Patients With Vitamin D Deficiency: A Randomized Clinical Trial, Journal of Research in Medical Sciences (2017)
22. Multiple Sclerosis-Related Fatigue Lacks a Unified Definition: A Narrative Review, Journal of Research in Medical Sciences (2022)
23. Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms, Asian Pacific Journal of Cancer Prevention (2024)
24. Outcome of Covid-19 Infection in Multiple Sclerosis Patients Receiving Disease-Modifying Therapies, Journal of Research in Medical Sciences (2021)
25. The Comparative Analysis of Serum Levels of Midkine in Patients With Multiple Sclerosis and Control Group, Journal of Isfahan Medical School (2013)
26. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study, Neurology (2022)
27. Prognostic Value of Intrathecal Igg Synthesis in Multiple Sclerosis: A Study in 54 Patients, Tehran University Medical Journal (2008)
28. The in Vitro Effects of Vitamin 1, 25(Oh) 2 D3 on Expression of Cytokines: In New-Onset Systemic Lupus Erythematosus Patients, Lupus (2022)
29. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
30. Co-Supplementation of Synbiotics and Anti-Inflammatory-Antioxidant Rich Diet in Patients With Progressive Forms of Multiple Sclerosis: A Single-Center, Randomized Clinical Trial, Mediterranean Journal of Nutrition and Metabolism (2024)
31. Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis, Journal of Cellular Physiology (2017)
32. Effects of Vitamin D on Retinal Nerve Fiber Layer in Vitamin D Deficient Patients With Optic Neuritis: Preliminary Findings of a Randomized, Placebo-Controlled Trial, Journal of Research in Medical Sciences (2015)
33. Th1, Th2 and Th17 Cytokine Profile in Patients With Multiple Sclerosis Following Treatment With Rapamycin, Iranian Journal of Immunology (2016)
34. The Role of Nutritional Factors During Adolescence in Multiple Sclerosis Onset: A Population-Based Incident Case–Control Study, Nutritional Neuroscience (2021)
35. Evaluation of the Prevalence of Bovine Leukemia Virus Dna in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, IJID Regions (2023)
36. Vitamin D Supplementation for Premenstrual Syndrome-Related Inflammation and Antioxidant Markers in Students With Vitamin D Deficient: A Randomized Clinical Trial, Scientific Reports (2019)
37. Prenatal and Perinatal Factors Associated With Developing Multiple Sclerosis Later in Life: A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2021)
38. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)
39. Evaluation of the Expressed Mir‑129 and Mir‑549A in Patients With Multiple Sclerosis, Advanced Biomedical Research (2021)
40. The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica, Basic and Clinical Neuroscience (2021)
41. The Effect of Ginger (Zingiber Officinale) Supplementation on Clinical, Biochemical, and Anthropometric Parameters in Patients With Multiple Sclerosis: A Double-Blind Randomized Controlled Trial, Food and Function (2023)
42. The Effects of Vitamin D Supplementation on Inflammatory Biomarkers in Patients With Abnormal Glucose Homeostasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Pharmacological Research (2021)
43. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)
44. Review on Selected Potential Nutritional Intervention for Treatment and Prevention of Viral Infections: Possibility of Recommending These for Coronavirus 2019, International Journal of Food Properties (2020)
45. Multiple Sclerosis Relapse After Covid-19 Vaccination: A Case Report-Based Systematic Review, Journal of Clinical Neuroscience (2022)
46. Active Form and Reservoir Form of Vitamin D in Children With Acute Lower Respiratory Infections and Its Association With Severity of the Infection, Archives of Pediatric Infectious Diseases (2019)
47. Neutralizing Antibodies in Multiple Sclerosis Patients on Weekly Intramuscular Avonex and Biosimilar Interferon Beta-1A (Cinnovex): Comparing Results of Measurements in Two Different Laboratories, Journal of Immunological Methods (2013)
48. Chlamydia Pneumoniae Seropositivity in Iranian Patients With Multiple Sclerosis: A Pilot Study; [Obecnosc Przeciwcial Przeciw Chlamydia Pneumoniae Wsrod Iranskich Chorych Na Stwardnienie Rozsiane: Badanie Pilotazowe], Neurologia i Neurochirurgia Polska (2011)
49. Biased Treg/Th17 Balance Away From Regulatory Toward Inflammatory Phenotype in Relapsed Multiple Sclerosis and Its Correlation With Severity of Symptoms, Journal of Neuroimmunology (2013)
50. Comparing the Improvement of Unstable Vitiligo in Patients Treated by Topical Puva-Therapy Alone, Topical Puva-Therapy and Oral Vitamin D, and Topical Puva-Therapy and Oral Vitamin D and Vitamin B12, Journal of Isfahan Medical School (2017)